Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals | Small Cap
Health Score : 8.46Rossari Biotech Ltd. presents a strong financial profile, characterized by exceptional growth, outstanding profitability, and a very secure, low-debt structure. The company is expanding rapidly, with significant increases in revenue, profits, and assets, indicating high market demand and substantial reinvestment for the future. Its ability to generate high returns on capital and equity is a key strength. However, the company's operational efficiency shows notable weaknesses. It is slow to collect payments from customers and does not generate revenue from its assets as effectively as it could. This indicates that while the company is growing, its management of working capital is an area of concern. The future outlook appears positive, driven by strong growth and profitability, but its performance will depend on improving the efficiency of its expanding asset base.
Health Score : 8.46Rossari Biotech Ltd. presents a strong financial profile, characterized by exceptional growth, outstanding profitability, and a very secure, low-debt structure. The company is expanding rapidly, with significant increases in revenue, profits, and assets, indicating high market demand and substantial reinvestment for the future. Its ability to generate high returns on capital and equity is a key strength. However, the company's operational efficiency shows notable weaknesses. It is slow to collect payments from customers and does not generate revenue from its assets as effectively as it could. This indicates that while the company is growing, its management of working capital is an area of concern. The future outlook appears positive, driven by strong growth and profitability, but its performance will depend on improving the efficiency of its expanding asset base.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
18.48
Industry Median
39.73
Small Cap Median
37.95
P/E RATIO
17.69
P/B RATIO
1.98
Industry Median
2.59
Small Cap Median
2.40
P/S RATIO
1.17
Industry Median
2.52
Small Cap Median
2.34
Others
PEG RATIO
0.00
EV/EBITDA RATIO
9.08
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹476.55 as on Sep 1, 2026.
Growth Score : 10.00The company is experiencing an exceptional period of expansion. It has demonstrated outstanding growth across all key metrics, including significant increases in sales, operating profits, and overall net income. This impressive performance is supported by a substantial increase in its asset base, indicating heavy investment in its future capabilities. This all-around high growth is a major strength, signaling strong market demand for its products and a successful business strategy that is driving the company forward.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 109.17 | 11.67 | 10.57 | 13.6 | 15.19 |
| Operating Profit Growth Rate | 48.39 | 21.2 | 12.11 | 6 | 7.92 |
| Earnings Per Share (EPS) Growth | 14.82 | 9.64 | 21.65 | 4.1 | 9.38 |
| Asset Growth Rate | 123.71 | 8.69 | 14.88 | 20.36 | 21.37 |
| Net Income Growth Rate | 22.5 | 9.18 | 22.43 | 3.82 | 9.56 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | J.G.Chemicals Ltd | 9.23 | 37.26 | Neutral | 82.00 | 5.47 | 69.00 |
| 2 | Platinum Industries Ltd | 8.59 | 24.08 | Neutral | 60.00 | 9.75 | 51.00 |
| 3 | Rossari Biotech Ltd | 8.46 | 17.69 | Neutral | 286.00 | 25.79 | 149.00 |
| 4 | Fineotex Chemical Ltd | 8.39 | 52.51 | Neutral | 135.00 | 0.79 | 125.00 |
| 5 | Vidhi Specialty Food Ingredients Ltd | 8.25 | 36.16 | Neutral | 78.00 | 9.84 | 49.00 |
| 6 | Bhansali Engineering Polymers Ltd | 8.25 | 17.56 | Undervalued | 216.00 | 7.25 | 180.00 |
| 7 | Styrenix Performance Materials Ltd | 8.12 | 19.35 | Neutral | 463.00 | 180.10 | 273.00 |
| 8 | Balaji Amines Ltd | 7.71 | 46.70 | Overvalued | 265.00 | 51.09 | 169.00 |
| 9 | Tatva Chintan Pharma Chem Ltd | 7.13 | 89.27 | Highly Overvalued | 93.00 | 16.71 | 42.00 |
| 10 | Neogen Chemicals Ltd | 6.69 | 197.61 | Highly Overvalued | 137.00 | 17.15 | 29.00 |
| 11 | Laxmi Organic Industries Ltd | 6.17 | 57.66 | Neutral | 171.00 | 2.86 | 79.00 |
| 12 | Yasho Industries Ltd | 6.09 | 203.81 | Neutral | 143.00 | 17.81 | 25.00 |
| 13 | Camlin Fine Sciences Ltd | 5.80 | 70.93 | Neutral | 107.00 | -1.72 | 24.00 |
| 14 | NOCIL Ltd | 5.27 | 50.94 | Neutral | 101.00 | 3.84 | 56.00 |
| 15 | Chemplast Sanmar Ltd | 4.81 | -9.62 | Neutral | 198.00 | -63.46 | -280.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Quarterly Report⬤27th Apr 26
Consolidated Financial Results for Q4 and Year Ended March 31, 2026
UNDEFINED SENTIMENT
Concall Report⬤23rd Jan 26
Q3 FY26 Earnings Conference Call
NEUTRAL SENTIMENT
No Stock News Available at This Moment.
Rossari Biotech Ltd. is a leading Indian specialty chemical manufacturer offering a diverse product portfolio across home, personal care & performance chemicals, textile specialty chemicals, and animal health & nutrition. The company focuses on sustainable and innovative solutions, serving various industries with a strong emphasis on research and development and a growing global footprint.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Rossari Biotech Ltd's P/E ratio (TTM) is 18.48, compared to the industry median of 39.73 and large cap median of 37.95.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Rossari Biotech Ltd's P/B ratio is 1.98, compared to the industry median of 2.59 and large cap median of 2.40.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Rossari Biotech Ltd's P/S ratio is 1.17, compared to the industry median of 2.52 and large cap median of 2.34.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Rossari Biotech Ltd's PEG ratio is 1.05.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Rossari Biotech Ltd's EV/EBITDA ratio is 9.08.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Rossari Biotech Ltd's ROE is 11.18%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Rossari Biotech Ltd's ROA is 12.49%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Rossari Biotech Ltd's ROCE is 15%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Rossari Biotech Ltd's operating margin is 11.94%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Rossari Biotech Ltd's net margin is 6.22%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Rossari Biotech Ltd's current ratio is 1.52.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Rossari Biotech Ltd's debt-to-equity ratio is 0.09.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Rossari Biotech Ltd's interest coverage ratio is 8.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Rossari Biotech Ltd's DPS is ₹0.54.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Rossari Biotech Ltd's EPS is 9.38.
(Source line: "Ratios as of 07 Oct 2026, based on last traded price of ₹476.55. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 2003
Headquarters: Mumbai, Maharashtra
Core Offerings: Home, Personal Care & Performance Chemicals, Textile Specialty Chemicals, Animal Health & Nutrition, Industrial Specialty Chemicals
Stock Listing: NSE (ROSSARI), BSE (543213)
Promoter: Edward Menezes and Sunil Chari (Co-Founders & Promoters)
2003: Incorporated. 2004: Began commercial production of textile specialty chemicals at Silvassa. 2009: Expanded into Home, Personal Care & Performance Chemicals. 2017: Expanded into Animal Health & Nutrition segment. 2020: Successfully completed IPO and listed on NSE and BSE. 2021: Acquired Unitop Chemicals Pvt Ltd, expanding into industrial specialties. 2022: Commissioned new manufacturing facility at Dahej, Gujarat, and acquired 51% stake in Tristar Intermediates Private Limited.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Home, Personal Care & Performance Chemicals | 50% | Operating Profit |
| Textile Specialty Chemicals | 21% | Operating Profit |
| Industrial Specialty Chemicals | 21% | Operating Profit |
| Animal Health & Nutrition | 8% | Operating Profit |
Home, Personal Care & Performance Chemicals (HPPC): Focuses on innovative solutions for home care products (detergents, cleaners) and personal care (cosmetics, toiletries), enhancing product efficacy and consumer experience.
Textile Specialty Chemicals (TSC): Provides a comprehensive range of chemicals for the entire textile processing value chain, including pre-treatment, dyeing, printing, and finishing for various fabrics and technical textiles.
Industrial Specialty Chemicals: Offers a diverse portfolio including emulsifiers, surfactants, and specialty formulations used across various industries like construction, paints, coatings, agrochemicals, and water treatment, significantly boosted by the Unitop acquisition.
Animal Health & Nutrition (AHN): Develops and manufactures specialized feed additives and nutritional supplements for poultry, aquaculture, and livestock, aimed at improving animal health, productivity, and overall farm economics.
Sunil Chari: Managing Director & CEO. He is a co-founder and has over three decades of experience in the specialty chemicals industry, driving the company's strategic growth and operational excellence.
Unitop Chemicals Private Limited
Tristar Intermediates Private Limited (51% stake)
Rossari Personal Care Private Limited
2020: Initial Public Offering (IPO). 2021: Acquired Unitop Chemicals Pvt Ltd. 2022: Acquired 51% stake in Tristar Intermediates Private Limited.
The Rossari Biotech Ltd share price today is ₹476.55 on NSE (ROSSARI), as of 08 Oct 2026.
As of 07 Oct 2026, Rossari Biotech Ltd share price is ₹476.55, with previous close ₹476.55. Today's range is ₹476.55 to ₹476.55. The 52-week range is ₹375 to ₹604.80.
As of today, Rossari Biotech Ltd's market cap is ₹2,792.58 crore (Small Cap).
Rossari Biotech Ltd's current P/E ratio is 18.48, compared to the CHEMICALS & PETROCHEMICALS sector average of 34.50.
Rossari Biotech Ltd's current P/B ratio is 1.98.
Rossari Biotech Ltd's current dividend yield is 0.11%. Last dividend of ₹0.80 per share was declared on 28-May-2024.
Rossari Biotech Ltd's EPS (TTM) is ₹9.38.
Rossari Biotech Ltd. is a leading Indian specialty chemical manufacturer offering a diverse product portfolio across home, personal care & performance chemicals, textile specialty chemicals, and animal health & nutrition. The company focuses on sustainable and innovative solutions, serving various industries with a strong emphasis on research and development and a growing global footprint.
Rossari Biotech Ltd is promoted by Edward Menezes and Sunil Chari (Co-Founders & Promoters), holding 68.15% as of 07 Oct 2026.
Rossari Biotech Ltd is listed on NSE (ROSSARI) and BSE (543213). Its next quarterly results are expected on August 2024 (for Q1 FY25).
Dividend Per Share (DPS)
Fixed Asset Turnover Ratio